The impact of both platinum-based chemotherapy and EGFR-TKIs on overall survival of patients with advanced non-small cell lung cancer

Both platinum-based doublet chemotherapy (PBC) and epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) prolong the survival of patients with advanced non-small cell lung cancer (NSCLC). In early studies, most patients underwent PBC as first-line treatment, but not all patients co...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian-Wei, Zhao, Yuan-Yuan, Guo, Ying, Xue, Cong, Hu, Zhi-Huang, Huang, Yan, Zhao, Hong-Yun, Zhang, Jing, Wu, Xuan, Fang, Wen-Feng, Ma, Yu-Xiang, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sun Yat-sen University Cancer Center 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935012/
https://www.ncbi.nlm.nih.gov/pubmed/23816558
http://dx.doi.org/10.5732/cjc.012.10274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935012/
https://www.ncbi.nlm.nih.gov/pubmed/23816558
http://dx.doi.org/10.5732/cjc.012.10274

Ejemplares similares